ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 256 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $266,000 | -69.1% | 5,791 | -55.4% | 0.00% | -100.0% |
| Q4 2021 | $861,000 | +19.7% | 12,986 | +12.8% | 0.00% | – |
| Q3 2021 | $719,000 | -15.1% | 11,512 | +12.5% | 0.00% | -100.0% |
| Q2 2021 | $847,000 | +31.5% | 10,233 | +5.3% | 0.00% | – |
| Q1 2021 | $644,000 | +16.2% | 9,718 | +34.7% | 0.00% | – |
| Q4 2020 | $554,000 | +99.3% | 7,214 | +11.8% | 0.00% | – |
| Q3 2020 | $278,000 | +12.1% | 6,453 | +12.5% | 0.00% | – |
| Q2 2020 | $248,000 | -73.6% | 5,735 | -82.5% | 0.00% | -100.0% |
| Q1 2020 | $941,000 | -51.5% | 32,711 | +7.0% | 0.00% | -50.0% |
| Q4 2019 | $1,939,000 | -45.9% | 30,572 | -76.0% | 0.00% | -50.0% |
| Q3 2019 | $3,587,000 | -25.1% | 127,295 | -29.6% | 0.00% | -20.0% |
| Q2 2019 | $4,788,000 | +378.3% | 180,693 | +231.3% | 0.01% | +400.0% |
| Q1 2019 | $1,001,000 | – | 54,541 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |